Business
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n\n TORONTO, ON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions to transfer part of its licensed woman’s diagnostic and treatment products to another company including additional territories and provides update on its Alliance joint venture partnership.\n On the heels of Easton’s and its partner BMV Medica’s recently announced sub distribution agreement with BAYER and the legal entity for their subsidiary company, Bayer Consumer Care AG for product VS-Sense, Easton / BMV have entered into negotiations with a possible new distribution partner for one of its other licensed products and additional territories. NDA’s have been executed with hopes for any finalized agreements to include an upfront cash payment and recurring royalties similar to its sub-distribution agreement reached with BAYER for product VS-Sense. Easton / BMV currently have 3 products launched following the previous two product launches with its sub distribution partner, Gedeon Richter Plc and their Mexican subsidiary company for “Gynofit” and AmnioSense”. In addition, Easton’s sub-distribution partner, Windsor Pharmaceuticals from Panama, has received approval for all products with sales status updates pending. As a result of the closed agreement with BAYER AG, Easton is nearing completed discussions with BMV Medica SA to acquire 100% of BMV and other products that they currently possess and / or have licensing rights towards. In other news, 1124123 Ontario Limited (o/a - Alliance Group) has had to delay its operations launch on its aggregate business to an anticipated mid March launch due to extreme weather conditions. Construction of facilities such as greenhouses for the cultivation of medical marijuana have also been delayed due to shortages and backlogs from manufacturers who specialize in these types of facilities. Although Alliance believes it has received an LP license exemption to grow marijuana to meet demand on the expected launch of medical / recreational marijuana in Canada later this summer, Easton / Alliance have received proposals and are nearing an expected agreement to proceed with its own LP application to become a legal grower on its 135 acres of property, part of which is zoned for agricultural use. More detailed updat...